<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39320390</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-9368</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>25</Day></PubDate></JournalIssue><Title>Transgenic research</Title><ISOAbbreviation>Transgenic Res</ISOAbbreviation></Journal><ArticleTitle>Characterizing a lethal CAG-ACE2 transgenic mouse model for SARS-CoV-2 infection using Cas9-enhanced nanopore sequencing.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11248-024-00413-w</ELocationID><Abstract><AbstractText>The SARS-CoV-2 pandemic has underscored the necessity for functional transgenic animal models for testing. Mouse lines with overexpression of the human receptor ACE2 serve as the common animal model to study COVID-19 infection. Overexpression of ACE2 under a strong ubiquitous promoter facilitates convenient and sensitive testing of COVID-19 pathology. We performed pronuclear microinjections using a 5 kb CAG-ACE2 linear transgene construct and identified three founder lines with 140, 72, and 73 copies, respectively. Two of these lines were further analyzed for ACE2 expression profiles and sensitivity to SARS-CoV-2 infection. Both lines expressed ACE2 in all organs analyzed. Embryonic fibroblast cell lines derived from transgenic embryos demonstrated severe cytopathic effects following infection, even at low doses of SARS-CoV-2 (0,1-1.0 TCID<sub>50</sub>). Infected mice from the two lines began to show COVID-19 clinical signs three days post-infection and succumbed between days 4 and 7. Histological examination of lung tissues from terminally ill mice revealed severe pathological alterations. To further characterize the integration site in one of the lines, we applied nanopore sequencing combined with Cas9 enrichment to examine the internal transgene concatemer structure. Oxford Nanopore sequencing (ONT) is becoming the gold standard for transgene insert characterization, but it is relatively inefficient without targeted region enrichment. We digested genomic DNA with Cas9 and gRNA against the ACE2 transgene to create ends suitable for ONT adapter ligation. ONT data analysis revealed that most of the transgene copies were arranged in a head-to-tail configuration, with palindromic junctions being rare. We also detected occasional plasmid backbone fragments within the concatemer, likely co-purified during transgene gel extraction, which is a common occurrence in pronuclear microinjections.</AbstractText><CopyrightInformation>© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smirnov</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia, 630090.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nurislamov</LastName><ForeName>Artem</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia, 630090.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Novosibirsk State University, Novosibirsk, Russia, 630090.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koncevaya</LastName><ForeName>Galina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia, 630090.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serova</LastName><ForeName>Irina</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia, 630090.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabirova</LastName><ForeName>Evelyn</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia, 630090.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chuyko</LastName><ForeName>Eduard</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia, 630090.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maltceva</LastName><ForeName>Ekaterina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Novosibirsk State University, Novosibirsk, Russia, 630090.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savoskin</LastName><ForeName>Maxim</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Novosibirsk State University, Novosibirsk, Russia, 630090.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zadorozhny</LastName><ForeName>Daniil</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Genetics and Life Science, Sirius University of Science and Technology, Sochi, Russia, 354340.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svyatchenko</LastName><ForeName>Victor A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>State Research Center for Virology and Biotechnology "Vector", Novosibirsk, Koltsovo, Russia, 630559.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Protopopova</LastName><ForeName>Elena V</ForeName><Initials>EV</Initials><AffiliationInfo><Affiliation>State Research Center for Virology and Biotechnology "Vector", Novosibirsk, Koltsovo, Russia, 630559.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taranov</LastName><ForeName>Oleg S</ForeName><Initials>OS</Initials><AffiliationInfo><Affiliation>State Research Center for Virology and Biotechnology "Vector", Novosibirsk, Koltsovo, Russia, 630559.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Legostaev</LastName><ForeName>Stanislav S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>State Research Center for Virology and Biotechnology "Vector", Novosibirsk, Koltsovo, Russia, 630559.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loktev</LastName><ForeName>Valery B</ForeName><Initials>VB</Initials><AffiliationInfo><Affiliation>Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia, 630090.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Novosibirsk State University, Novosibirsk, Russia, 630090.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Research Center for Virology and Biotechnology "Vector", Novosibirsk, Koltsovo, Russia, 630559.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serov</LastName><ForeName>Oleg</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia, 630090.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Novosibirsk State University, Novosibirsk, Russia, 630090.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Battulin</LastName><ForeName>Nariman</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Cytology and Genetics SB RAS, Novosibirsk, Russia, 630090. battulin@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Novosibirsk State University, Novosibirsk, Russia, 630090. battulin@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>agreement № 075-15-2024-539 signed 24.04.2024</GrantID><Agency>Ministry of Science and Higher Education of the Russian Federation</Agency><Country /></Grant><Grant><GrantID>agreement № 075-15-2024-539 signed 24.04.2024</GrantID><Agency>Ministry of Science and Higher Education of the Russian Federation</Agency><Country /></Grant><Grant><GrantID>agreement № 075-15-2024-539 signed 24.04.2024</GrantID><Agency>Ministry of Science and Higher Education of the Russian Federation</Agency><Country /></Grant><Grant><GrantID>agreement № 075-15-2024-539 signed 24.04.2024</GrantID><Agency>Ministry of Science and Higher Education of the Russian Federation</Agency><Country /></Grant><Grant><GrantID>agreement № 075-15-2024-539 signed 24.04.2024</GrantID><Agency>Ministry of Science and Higher Education of the Russian Federation</Agency><Country /></Grant><Grant><GrantID>agreement № 075-15-2024-539 signed 24.04.2024</GrantID><Agency>Ministry of Science and Higher Education of the Russian Federation</Agency><Country /></Grant><Grant><GrantID>agreement № 075-15-2024-539 signed 24.04.2024</GrantID><Agency>Ministry of Science and Higher Education of the Russian Federation</Agency><Country /></Grant><Grant><GrantID>FWNR-2022-0019</GrantID><Agency>Ministry of Science and Higher Education of the Russian Federation</Agency><Country /></Grant><Grant><GrantID>grant #FSUS-2024-0018</GrantID><Agency>Ministry of Education and Science of the Russian Federation</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Transgenic Res</MedlineTA><NlmUniqueID>9209120</NlmUniqueID><ISSNLinking>0962-8819</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Mouse model</Keyword><Keyword MajorTopicYN="N">Nanopore sequencing</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Transgenic mice</Keyword><Keyword MajorTopicYN="N">hACE2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>11</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39320390</ArticleId><ArticleId IdType="doi">10.1007/s11248-024-00413-w</ArticleId><ArticleId IdType="pii">10.1007/s11248-024-00413-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anand RP, Layer JV, Heja D et al (2023) Design and testing of a humanized porcine donor for xenotransplantation. Nature 622:393–401. https://doi.org/10.1038/s41586-023-06594-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06594-4</ArticleId><ArticleId IdType="pubmed">37821590</ArticleId><ArticleId IdType="pmc">10567564</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao L, Deng W, Huang B, et al (2020) The Pathogenicity of SARS-CoV-2 in hACE2 Transgenic Mice. bioRxiv 2020.02.07.939389. https://doi.org/10.1101/2020.02.07.939389</Citation></Reference><Reference><Citation>Battulin N, Korablev A, Ryzhkova A et al (2022) The human EF1a promoter does not provide expression of the transgene in mice. Transgenic Res 31:525–535. https://doi.org/10.1007/s11248-022-00319-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11248-022-00319-5</ArticleId><ArticleId IdType="pubmed">35960480</ArticleId><ArticleId IdType="pmc">9372930</ArticleId></ArticleIdList></Reference><Reference><Citation>Battulin NR, Serov OL (2022) Creation of transgenic mice susceptible to coronaviruses: a platform for studying viral pathogenesis and testing vaccines. Vavilovskii Zhurnal Genet Selektsii 26:402–408. https://doi.org/10.18699/VJGB-22-49</Citation></Reference><Reference><Citation>Bruter AV, Korshunova DS, Kubekina MV et al (2021) Novel transgenic mice with Cre-dependent co-expression of GFP and human ACE2: a safe tool for study of COVID-19 pathogenesis. Transgenic Res 30:289–301. https://doi.org/10.1007/s11248-021-00249-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11248-021-00249-8</ArticleId><ArticleId IdType="pubmed">33855640</ArticleId><ArticleId IdType="pmc">8045570</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryant WB, Yang A, Griffin SH et al (2023) CRISPR-Cas9 Long-Read Sequencing for Mapping Transgenes in the Mouse Genome. CRISPR J 6:163–175. https://doi.org/10.1089/crispr.2022.0099</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/crispr.2022.0099</ArticleId><ArticleId IdType="pubmed">37071672</ArticleId><ArticleId IdType="pmc">10123806</ArticleId></ArticleIdList></Reference><Reference><Citation>Clever S, Volz A (2023) Mouse models in COVID-19 research: analyzing the adaptive immune response. Med Microbiol Immunol 212:165–183. https://doi.org/10.1007/s00430-022-00735-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-022-00735-8</ArticleId><ArticleId IdType="pubmed">35661253</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolskiy AA, Gudymo AS, Taranov OS et al (2021) The Tissue Distribution of SARS-CoV-2 in Transgenic Mice With Inducible Ubiquitous Expression of hACE2. Front Mol Biosci 8:821506. https://doi.org/10.3389/fmolb.2021.821506</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.821506</ArticleId><ArticleId IdType="pubmed">35118120</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilpatrick T, Lee I, Graham JE et al (2020) Targeted nanopore sequencing with Cas9-guided adapter ligation. Nat Biotechnol 38:433–438. https://doi.org/10.1038/s41587-020-0407-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-020-0407-5</ArticleId><ArticleId IdType="pubmed">32042167</ArticleId><ArticleId IdType="pmc">7145730</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang R-D, Liu M-Q, Chen Y et al (2020) Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2. Cell 182:50-58.e8. https://doi.org/10.1016/j.cell.2020.05.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.027</ArticleId><ArticleId IdType="pubmed">32516571</ArticleId><ArticleId IdType="pmc">7241398</ArticleId></ArticleIdList></Reference><Reference><Citation>Jupe F, Rivkin AC, Michael TP et al (2019) The complex architecture and epigenomic impact of plant T-DNA insertions. PLoS Genet 15:e1007819. https://doi.org/10.1371/journal.pgen.1007819</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007819</ArticleId><ArticleId IdType="pubmed">30657772</ArticleId><ArticleId IdType="pmc">6338467</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuba K, Imai Y, Ohto-Nakanishi T, Penninger JM (2010) Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol Ther 128:119–128. https://doi.org/10.1016/j.pharmthera.2010.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2010.06.003</ArticleId><ArticleId IdType="pubmed">20599443</ArticleId><ArticleId IdType="pmc">7112678</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Moore MJ, Vasllieva N et al (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450–454. https://doi.org/10.1038/nature02145</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02145</ArticleId><ArticleId IdType="pubmed">14647384</ArticleId><ArticleId IdType="pmc">7095016</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Zhang M, Wu B et al (2024) A highly susceptible hACE2-transgenic mouse model for SARS-CoV-2 research. Front Microbiol 15:1348405. https://doi.org/10.3389/fmicb.2024.1348405</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2024.1348405</ArticleId><ArticleId IdType="pubmed">38389533</ArticleId><ArticleId IdType="pmc">10883650</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F-L, Wu K, Sun J, et al (2021) Rapid generation of ACE2 humanized inbred mouse model for COVID-19 with tetraploid complementation. Natl Sci Rev 8:nwaa285. https://doi.org/10.1093/nsr/nwaa285</Citation></Reference><Reference><Citation>Low BE, Hosur V, Lesbirel S, Wiles MV (2022) Efficient targeted transgenesis of large donor DNA into multiple mouse genetic backgrounds using bacteriophage Bxb1 integrase. Sci Rep 12:1–16. https://doi.org/10.1038/s41598-022-09445-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-09445-w</ArticleId></ArticleIdList></Reference><Reference><Citation>McCray PB, Pewe L, Wohlford-Lenane C et al (2007) Lethal Infection of K18-hACE2 Mice Infected with Severe Acute Respiratory Syndrome Coronavirus. J Virol 81:813–821. https://doi.org/10.1128/jvi.02012-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02012-06</ArticleId><ArticleId IdType="pubmed">17079315</ArticleId></ArticleIdList></Reference><Reference><Citation>Menachery VD, Yount BL, Sims AC et al (2016) SARS-like WIV1-CoV poised for human emergence. Proc Natl Acad Sci U S A 113:3048–3053. https://doi.org/10.1073/pnas.1517719113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1517719113</ArticleId><ArticleId IdType="pubmed">26976607</ArticleId><ArticleId IdType="pmc">4801244</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholls PK, Bellott DW, Cho T-J, et al (2019) Locating and Characterizing a Transgene Integration Site by Nanopore Sequencing. G3; Genes|Genomes|Genetics 9:1481–1486. https://doi.org/10.1534/g3.119.300582</Citation></Reference><Reference><Citation>Niks M, Otto M (1990) Towards an optimized MTT assay. J Immunol Methods 130:149–151. https://doi.org/10.1016/0022-1759(90)90309-j</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-1759(90)90309-j</ArticleId><ArticleId IdType="pubmed">2358686</ArticleId></ArticleIdList></Reference><Reference><Citation>Quick J (2018) Ultra-long read sequencing protocol for Oxford Nanopore</Citation></Reference><Reference><Citation>Smirnov A, Battulin N (2021) Concatenation of Transgenic DNA: Random or Orchestrated? Genes 12:1969. https://doi.org/10.3390/genes12121969</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes12121969</ArticleId><ArticleId IdType="pubmed">34946918</ArticleId><ArticleId IdType="pmc">8701086</ArticleId></ArticleIdList></Reference><Reference><Citation>Smirnov A, Fishman V, Yunusova A et al (2019) DNA barcoding reveals that injected transgenes are predominantly processed by homologous recombination in mouse zygote. Nucleic Acids Res. https://doi.org/10.1093/nar/gkz1085</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz1085</ArticleId><ArticleId IdType="pubmed">30395270</ArticleId><ArticleId IdType="pmc">7145541</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun SH, Chen Q, Gu HJ et al (2020) A Mouse Model of SARS-CoV-2 Infection and Pathogenesis. Cell Host Microbe 28:124-133.e4. https://doi.org/10.1016/j.chom.2020.05.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.05.020</ArticleId><ArticleId IdType="pubmed">32485164</ArticleId><ArticleId IdType="pmc">7250783</ArticleId></ArticleIdList></Reference><Reference><Citation>Svyatchenko VA, Nikonov SD, Mayorov AP et al (2021) Antiviral photodynamic therapy: Inactivation and inhibition of SARS-CoV-2 in vitro using methylene blue and Radachlorin. Photodiagnosis Photodyn Ther 33:102112. https://doi.org/10.1016/j.pdpdt.2020.102112</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pdpdt.2020.102112</ArticleId><ArticleId IdType="pubmed">33249118</ArticleId></ArticleIdList></Reference><Reference><Citation>Svyatchenko VA, Ternovoi VA, Lutkovskiy RY et al (2023) Human Adenovirus and Influenza A Virus Exacerbate SARS-CoV-2 Infection in Animal Models. Microorganisms 11:180. https://doi.org/10.3390/microorganisms11010180</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11010180</ArticleId><ArticleId IdType="pubmed">36677472</ArticleId><ArticleId IdType="pmc">9860643</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng C-TK, Huang C, Newman P et al (2007) Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor. J Virol 81:1162–1173. https://doi.org/10.1128/JVI.01702-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01702-06</ArticleId><ArticleId IdType="pubmed">17108019</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang XH, Deng W, Tong Z et al (2007) Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection. Comp Med 57:450–459</Citation><ArticleIdList><ArticleId IdType="pubmed">17974127</ArticleId></ArticleIdList></Reference><Reference><Citation>Yinda CK, Port JR, Bushmaker T et al (2021) K18-hACE2 mice develop respiratory disease resembling severe COVID-19. PLoS Pathog 17:e1009195. https://doi.org/10.1371/journal.ppat.1009195</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009195</ArticleId><ArticleId IdType="pubmed">33465158</ArticleId><ArticleId IdType="pmc">7875348</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoyama M, Fujita T, Kadonosawa Y et al (2023) Development of transgenic mice overexpressing mouse carbonyl reductase 1. Mol Biol Rep 50:531–540. https://doi.org/10.1007/s11033-022-07994-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-022-07994-x</ArticleId><ArticleId IdType="pubmed">36352178</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>